World's Best Scientists 2026 revealed!
Oncology Reports
H-index 23

Oncology Reports

1021-335X

Published by: Spandidos Publications

https://www.spandidos-publications.com/or

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1702 58 65 15

Additional Metrics

Number of Best Scientists*: 256
Documents by Best Scientists*: 242
Top 100 Ranked Scientists*: 8
SCIMAGO H-index: 120
SCIMAGO SJR: 0.915
Impact Factor: 3.9

Overview

Top Research Topics at Oncology Reports?

Oncology Reports investigates studies in Cancer research, Cell cycle, Cancer, Oncogene and Cell. The concepts on Cancer research presented in the journal can also apply to other research fields, including Protein kinase B, Carcinogenesis, Cancer cell, Downregulation and upregulation and PI3K/AKT/mTOR pathway. The work on Cell cycle tackled in the journal brings together disciplines like Cell culture, Cell growth, Molecular biology and Cell biology.

The in-depth study on Cancer also explores topics in the intersecting field of Pathology. The work on Pathology addressed in it expands to the thematically related Adenocarcinoma. Oncology Reports focuses on Oncogene but the discussions also offer insight into other areas such as Gene knockdown, Molecular medicine, microRNA, Tumor progression and Regulation of gene expression.

Signal transduction and Transfection are some topics wherein Cell research discussed in the journal have an impact. Apoptosis research presented in it encompasses a variety of subjects, including Immunology and Pharmacology. Topics in Internal medicine were tackled in line with various other fields like Gastroenterology, Endocrinology, Surgery and Oncology.

  • Cancer research (56.27%)
  • Cell cycle (44.38%)
  • Cancer (44.25%)

What are the most cited papers published in the journal?

  • Cisplatin and platinum drugs at the molecular level. (Review). (657 citations)
  • Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade (Review) (347 citations)
  • WNT/PCP signaling pathway and human cancer (review). (339 citations)

Research areas of the most cited articles at Oncology Reports:

The published articles tackle a plethora of topics, such as Cancer research, Cancer, Oncogene, Cell cycle and Pathology. The journal articles hold forums on Cancer research that merge themes from other disciplines such as Cell culture, Protein kinase B, Carcinogenesis, Cancer cell and Immunology. The works on Cell cycle tackled in the published papers bring together disciplines like Molecular biology, Cell growth and Cell biology.

What topics the last edition of the journal is best known for?

  • Gene
  • Cancer
  • Internal medicine

The previous edition focused in particular on these issues:

The main points discussed in the journal deals with Cancer research, Cell cycle, Oncogene, Cancer and Cell. While Cancer research is the focus of Oncology Reports, it also provided insights into the studies of Molecular medicine, Carcinogenesis, Apoptosis, microRNA and Metastasis. It explores issues in Cell cycle which can be linked to other research areas like Cell culture, Gene knockdown, Protein kinase B, Cell growth and Cell biology.

The studies in Oncogene featured incorporate elements of Epithelial–mesenchymal transition, Downregulation and upregulation, Cancer cell, Tumor progression and Gene silencing. The featured Cancer research is covered under the field of Internal medicine. The research on Cell featured in Oncology Reports combines topics in other fields like Wnt signaling pathway, Flow cytometry, Long non-coding RNA and Glioma.

The most cited articles from the last journal are:

  • Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment (6 citations)
  • Exosome-mediated radiosensitizing effect on neighboring cancer cells via increase in intracellular levels of reactive oxygen species. (5 citations)
  • Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Oncology Reports (based on the number of publications) are:

  • Masaki Mori (46 papers) absent at the last edition,
  • Hiroyasu Makuuchi (46 papers) absent at the last edition,
  • Masaya Mukai (44 papers) absent at the last edition,
  • Demetrios A. Spandidos (38 papers) published 1 paper at the last edition, 3 less than at the previous edition,
  • Yung Hyun Choi (38 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Oncology Reports (based on the number of publications) are:

  • Xi'an Jiaotong University (258 papers) published 13 papers at the last edition, 9 less than at the previous edition,
  • Shanghai Jiao Tong University (246 papers) published 8 papers at the last edition, 2 less than at the previous edition,
  • Shandong University (202 papers) published 3 papers at the last edition, 11 less than at the previous edition,
  • Sun Yat-sen University (193 papers) published 2 papers at the last edition, 9 less than at the previous edition,
  • Jilin University (191 papers) published 13 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.87% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 23.98% were posted by at least one author from the top 10 institutions publishing in the journal. Another 13.01% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.48% of all publications and 45.53% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Oncology Research

In addition to offering a wide variety of topics for exploration, a career in oncology research can provide a plethora of opportunities for advancement and specialization. Whether one is intrigued by the mysteries of the cell cycle, passionate about unearthing the molecular mechanisms of cancer, or eager to study the role of oncogenes, the field promises numerous fascinating research paths. Much like the branching pathways in a cell, a career in oncology research can diversify into a variety of related disciplines, such as pharmacology, molecular biology, cell biology, and internal medicine. The broad spectrum of this discipline allows for an expansive career path, which may lead to breakthroughs in cancer prevention, treatment, and even a potential cure. While the field of oncology research can be challenging, it is equally rewarding. Notably, oncology researchers often work in a dynamic, interdisciplinary environment, collaborating with other scientists, doctors, and healthcare professionals. In so doing, researchers have the opportunity to make a meaningful impact not only on patients but also on the wider medical fields. For those considering a career in oncology research, pursuing related educational paths, such as a Licensed Practical Nurse (LPN) program, could provide a stepping-stone into the field. Prospective nurses who wish to specialize in oncology could consider enrolling in an LPN program. For instance, there are several notable lpn programs new mexico that provide the necessary practical experience and theoretical knowledge to succeed in this field. Overall, a career in oncology research is not just about making significant strides in cancer research and treatment. It is also about affecting lives, both directly and indirectly, creating a ripple effect of positive change in the medical world and beyond.

Top Publications

  • Inhibition of the VEGF signaling pathway attenuates tumor-associated macrophage activity in liver cancer

    (2022)
    56 Citations
  • Blue light irradiation inhibits the growth of colon cancer and activation of cancer-associated fibroblasts

    (2022)
    27 Citations
  • Sensitivity of allyl isothiocyanate to induce apoptosis via ER stress and the mitochondrial pathway upon ROS production in colorectal adenocarcinoma cells.

    Jo‑Hua Chiang;Fuu‑Jen Tsai;Yuan‑Man Hsu;Mei‑Chin Yin

    (2020)
    26 Citations
  • What is considered cardiotoxicity of anthracyclines in animal studies.

    Nikolaos Georgiadis;Konstantinos Tsarouhas;Ramin Rezaee;Haritini Nepka

    (2020)
    26 Citations
  • Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma

    (2020)
    25 Citations
  • ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.

    Ken Tanaka;Shuya Kandori;Shotaro Sakka;Satoshi Nitta

    (2022)
    24 Citations
  • Novel quinazolinone MJ‑33 induces AKT/mTOR‑mediated autophagy‑associated apoptosis in 5FU‑resistant colorectal cancer cells

    Hai‑Anh Ha;Jo‑Hua Chiang;Fuu‑Jen Tsai;Da‑Tian Bau

    (2020)
    23 Citations
  • Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma.

    Yuuki Ohara;Atsushi Enomoto;Yuta Tsuyuki;Kotaro Sato

    (2020)
    23 Citations
  • Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth in vivo in head and neck cancer models.

    A R M Ruhul Amin;Dongsheng Wang;Sreenivas Nannapaneni;Rajan Lamichhane

    (2021)
    21 Citations
  • Galectin‑9 suppresses the tumor growth of colon cancer in vitro and in vivo.

    Asahiro Morishita;Kei Nomura;Joji Tani;Koji Fujita

    (2021)
    20 Citations

Related Online Degrees & Career Pathways

For those interested in Medicine in the USA, exploring related online degrees can open up diverse career pathways in healthcare. Many students begin with nursing programs, such as the shortest rn to bsn program options that allow registered nurses to quickly advance their education and broaden their clinical skills. These accelerated paths are perfect for working professionals seeking career growth without long breaks from employment.

Another key option is transitioning from ADN to advanced practice roles. The adn to np programs provide a streamlined route for associate degree nurses to become nurse practitioners, significantly expanding their scope and responsibilities in patient care.

For those without a nursing background, online direct entry msn programs offer an accessible way to enter the nursing profession at the graduate level. These programs provide a fast-tracked education for non-nurses to earn their MSN and qualify for various advanced roles.

When choosing a program, factors like accreditation, flexibility, and reputation matter. Comparing institutions, such as in the capella university vs wgu rn to bsn analysis, helps prospective students make informed decisions aligned with their career goals.

Best Scientists Contributing to This Journal